Genetech has submitted a New Drug Application for vismodegib to the U.S. Food and Drug Administration (FDA) for the treatment of people with advanced basal cell carcinoma (BCC) for whom surgery is considered inappropriate. BCC is the most common type of skin cancer which affects thousands of people each year. Most BCCs are easily treated through surgery. However, if left […]

USF dermatologist develops rapid immunostain technique Word is spreading about a time-saving improvement to traditional Mohs surgery, a specialized outpatient method for treating certain skin cancers. Since his break-through article (published last summer in the journal Dermatologic Surgery) revealed an improved technique that reduced the time for the immunostaining component of Mohs surgery from an hour to 19 minutes, USF’s […]